|
[1]
|
van der Feltz-Cornelis, C.M. and van Houdenhove, B. (2014) [DSM-5: From ‘Somatoform Disorders’ to ‘Somatic Symptom and Related Disorders’]. Tijdschrift voor Psychiatrie, 56, 182-186.
|
|
[2]
|
Oyama, O., Paltoo, C. and Greengold, J. (2007) Somatoform Disorders. American Family Physician, 76, 1333-1338.
|
|
[3]
|
Löwe, B., Toussaint, A., Rosmalen, J.G.M., Huang, W., Burton, C., Weigel, A., et al. (2024) Persistent Physical Symptoms: Definition, Genesis, and Management. The Lancet, 403, 2649-2662. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Arrieta, O., Cárdenas-Fernández, D., Rodriguez-Mayoral, O., Gutierrez-Torres, S., Castañares, D., Flores-Estrada, D., et al. (2024) Mirtazapine as Appetite Stimulant in Patients with Non-Small Cell Lung Cancer and Anorexia: A Randomized Clinical Trial. JAMA Oncology, 10, 305-314. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Huang, W., Chen, I., Chang, F. and Liao, S. (2016) Somatic Symptom Disorder and Undifferentiated Somatoform Disorder, Which Is Broader? Response to “Clinical Value of DSM IV and DSM 5 Criteria for Diagnosing the Most Prevalent Somatoform Disorders in Patients with Medically Unexplained Physical Symptoms (MUPS)”. Journal of Psychosomatic Research, 89, 114-115. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Boeckle, M., Schrimpf, M., Liegl, G. and Pieh, C. (2016) Neural Correlates of Somatoform Disorders from a Meta-Analytic Perspective on Neuroimaging Studies. NeuroImage: Clinical, 11, 606-613. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Xiao, P., Li, C., Mi, J. and Wu, J. (2024) Evaluating the Distinct Effects of Body Mass Index at Childhood and Adulthood on Adult Major Psychiatric Disorders. Science Advances, 10, eadq2452. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Mitchell, J.E. and Peterson, C.B. (2020) Anorexia Nervosa. New England Journal of Medicine, 382, 1343-1351. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Zimmerman, J. and Fisher, M. (2017) Avoidant/restrictive Food Intake Disorder (ARFID). Current Problems in Pediatric and Adolescent Health Care, 47, 95-103. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Kouhestani, E., Minaei, R., Salimi, A., Mehrabi, Y. and Meshkat, S. (2023) The Analgesic Effect and Safety of Duloxetine in Total Knee Arthroplasty: A Systematic Review. Journal of Orthopaedic Surgery, 31, 1-11. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Hassanein, E.H.M., Althagafy, H.S., Baraka, M.A., Abd-Alhameed, E.K. and Ibrahim, I.M. (2023) Pharmacological Update of Mirtazapine: A Narrative Literature Review. Naunyn-Schmiedeberg’s Archives of Pharmacology, 397, 2603-2619. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Peng, C., Xue, L., Yue, Y., Chen, W., Wang, W. and Shen, J. (2023) Duloxetine HCL Alleviates Asthma Symptoms by Regulating PI3K/AKT/mTOR and Nrf2/HO-1 Signaling Pathways. Inflammation, 46, 2449-2469. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Dunlop, B.W., Cha, J., Choi, K.S., Rajendra, J.K., Nemeroff, C.B., Craighead, W.E., et al. (2023) Shared and Unique Changes in Brain Connectivity among Depressed Patients after Remission with Pharmacotherapy versus Psychotherapy. American Journal of Psychiatry, 180, 218-229. [Google Scholar] [CrossRef] [PubMed]
|